News Articles GT Medical Technologies, Inc. Secures $35 Million Venture Loan Facility from Horizon Technology Finance
Press Releases GammaTile® Marks Milestone: 100th Patient Enrolled in Groundbreaking ROADS Phase 3 Clinical Trial for Newly Diagnosed Metastatic Brain Tumors
News Articles Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors
Press Releases GT Medical Technologies, Inc. Presents New Data Further Demonstrating High Local Control for the Treatment of Recurrent Brain Metastases at ASTRO 2023
Press Releases GT Medical Technologies Marks a Clinical Milestone: 200th Patient Enrolled in the Multicenter Observational Registry of GammaTile® Therapy